AB Sagax
Short position disclosed on April 17, 2026.
0.59% of the capital sold short
1 disclosing funds
6 disclosures on record
SE0005127818 ISIN code
Funds holding AB Sagax Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
August 4, 2025 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Arrowstreet Capital Limited Partnership | 0.59% | +0.09 pt | April 17, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| April 17, 2026 | Arrowstreet Capital Limited Partnership | 0.59% | still open |
| February 18, 2026 | Arrowstreet Capital Limited Partnership | 0.69% | still open |
| February 11, 2026 | JPMorgan Asset Management (UK) Ltd | 0.50% | still open |
| September 9, 2025 | Arrowstreet Capital Limited Partnership | 0.70% | still open |
| August 27, 2025 | Arrowstreet Capital Limited Partnership | 0.60% | still open |
| August 4, 2025 | Arrowstreet Capital Limited Partnership | 0.50% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
- Elekta AB (publ) 10.19% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Embracer Group AB 5.25% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Dynavox Group AB 4.30% of the capital sold short
- RaySearch Laboratories AB (publ) 4.15% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, AB Sagax, source Finansinspektionen, data as at April 17, 2026, https://www.quivad.com/action/ab-sagax